KEY FEATURES
| Full Name | Transforming Growth Factor Beta 1 |
|---|---|
| Synonym | TGF-B1; CED; DPD1; LAP; Camurati-Engelmann Disease; Latency-associated peptide |
| Assay Type | Sandwich |
| Reactivity | Human |
| Range | 15.6-1000pg/mL |
| Sensitivity | 6.2pg/mL |
| Sample Type | Serum,plasma and other biological fluids |
| Sample Volume | 100μL |
| Detection Wavelength | OD450 |
| Transportation Temperature | 2-8°C |
| Specificity | The kit detected Human TGFb1 in the samples and no significant cross-species reactions were found |
| Microplate | 96-wells plate breakable into 12 x 8 wells strip |
TEST PRINCIPLE
| This ELISA kit uses the Sandwich-ELISA principle. The micro ELISA plate provided in this kit has been pre-coated with an antibody specific to Human TGFb1. Standards or samples are added to the micro ELISA plate wells and combined with the specific antibody. Then a biotinylated detection antibody specific for Human TGFb1 and Avidin-Horseradish Peroxidase (HRP) conjugate are added successively to each micro plate well and incubated. Free components are washed away. The substrate solution is added to each well. Only those wells that contain Human TGFb1, biotinylated detection antibody and Avidin-HRP conjugate will appear blue in color. The enzyme-substrate reaction is terminated by the addition of stop solution and the color turns yellow. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The OD value is proportional to the concentration of Human TGFb1. You can calculate the concentration of Human TGFb1 in the samples by comparing the OD of the samples to the standard curve. |
ELISA KIT COMPONENTS
Upon receipt, unpack promptly and store as recommended in the instructions.
| Components | Specifications | Storage and Notes |
|---|---|---|
| Micro Plate | 96T: 8 wells×12 strips 48T: 8 wells×6 strips | Unopened: -20°C, 12 months Unused: Put it back in the aluminum foil bag and seal it, store it at -20°C. |
| Reference Standard | 96T: 2 vials 48T: 1 vial | Unopened: -20°C, 12 months Please use freshly dissolved standards for each experiment. Discard any unused standards after dissolution. |
| Biotinylated Detection Ab Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C, 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| HRP Conjugate Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C(Protect from light), 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| Biotinylated Detection Ab Diluent | 14mL×1 | 2-8℃, 12 months |
| HRP Conjugate Diluent | 14mL×1 | 2-8℃, 12 months |
| Reference Standard & Sample Diluent | 20mL×1 | 2-8℃, 12 months |
| Washing Buffer Concentrate (25×) | 30mL×1 | 2-8℃, 12 months |
| Substrate Reagent(TMB) | 10mL×1 | 2-8°C(Protect from light),12 months |
| Stop Solution | 7mL×1 | 2-8°C/Room temperature |
ASSAY PROCEDURES

TYPICAL DATA

Human TGFb1 ELISA Standard Curve
Typical data are for reference only and curves should be replotted for each experiment. The Logistics function is recommended for fitting.
PRECISION
Intra-Assay Precision (Precision within an assay): Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.
Inter-Assay Precision (Precision between assays): Three samples of known concentration were tested in twenty separate assays to assess inter-assay precision. Assays were performed by at least three technicians using two lots of components.
| Intra-assay Precision | Inter-assay Precision | |||||
|---|---|---|---|---|---|---|
| Sample | 1 | 2 | 3 | 1 | 2 | 3 |
| n | 20 | 20 | 20 | 20 | 20 | 20 |
| Mean (pg/mL) | 45.74 | 145.12 | 401.56 | 45.7 | 131.59 | 403.07 |
| Standard deviation | 3.07 | 6.14 | 15.06 | 2.35 | 5.59 | 13.46 |
| CV(%) | 6.71 | 4.23 | 3.75 | 5.14 | 4.25 | 3.34 |
RECOVERY
The recovery of Human TGFb1 spiked to three different levels in samples throughout the range of the assay in various matrices was evaluated.
| Sample Type | Range (%) | Average Recovery (%) |
|---|---|---|
| Serum(n=8) | 89-101 | 95 |
| EDTA plasma (n=8) | 89-102 | 94 |
| Cell culture media (n=8) | 86-98 | 92 |
LINEARITY
To assess the linearity of the assay, samples containing and/or spiked with high concentrations of Human TGFb1 in various matrices were diluted with the Reference Standard & Sample Diluent to produce samples with values within the dynamic range of the assay.

Products associated with TGFB1 ELISA Kits
| SMAD2 ELISA Kit | publications with TGFB1 and SMAD2 |
| SMAD7 ELISA Kit | publications with TGFB1 and SMAD7 |
| TGFBR3 ELISA Kit | publications with TGFB1 and TGFBR3 |
| DCN ELISA Kit | publications with TGFB1 and DCN |
| TIMP1 ELISA Kit | publications with TGFB1 and TIMP1 |
| TGFBR2 ELISA Kit | publications with TGFB1 and TGFBR2 |
| TGFBR1 ELISA Kit | publications with TGFB1 and TGFBR1 |
| LTBP1 ELISA Kit | publications with TGFB1 and LTBP1 |
| FN1 ELISA Kit | publications with TGFB1 and FN1 |
Pathways associated with TGFB1 ELISA Kit
| ACE Inhibitor Pathway | ACE Inhibitor Pathway |
| ALK1 Signaling Events Pathway | ALK1 Signaling Events Pathway |
| Adipogenesis Pathway | Adipogenesis Pathway |
| Amoebiasis Pathway | Amoebiasis Pathway |
| Cardiac Progenitor Differentiation Pathway | Cardiac Progenitor Differentiation Pathway |
| Cell Cycle Pathway | Cell Cycle Pathway |
| Chagas Disease (American Trypanosomiasis) Pathway | Chagas Disease (American Trypanosomiasis) Pathway |
Diseases associated with TGFB1 ELISA Kit
| Fibrosis | publications with TGFB1 and Fibrosis |
| Lung Diseases | publications with TGFB1 and Lung Diseases |
| Liver Cirrhosis | publications with TGFB1 and Liver Cirrhosis |
| Pulmonary Fibrosis | publications with TGFB1 and Pulmonary Fibrosis |
| Hypertension | publications with TGFB1 and Hypertension |
| Proteinuria | publications with TGFB1 and Proteinuria |
| Diabetic Nephropathies | publications with TGFB1 and Diabetic Nephropathies |
| Hypersensitivity | publications with TGFB1 and Hypersensitivity |
| Asthma | publications with TGFB1 and Asthma |
| Diabetes Mellitus, Experimental | publications with TGFB1 and Diabetes Mellitus, Experimental |
Organs/Tissues associated with TGFB1 ELISA Kit
| Blood | publications with TGFB1 and Blood |
| Muscle | publications with TGFB1 and Muscle |
| Kidney | publications with TGFB1 and Kidney |
| Bone | publications with TGFB1 and Bone |
| Lung | publications with TGFB1 and Lung |
| Liver | publications with TGFB1 and Liver |
| Connective Tissue | publications with TGFB1 and Connective Tissue |
| Skin | publications with TGFB1 and Skin |
| Heart | publications with TGFB1 and Heart |
| Bone Marrow | publications with TGFB1 and Bone Marrow |